The
NENEXP project is
a multi-centre cohort study of mothers and children exposed to
antiretroviral treatment during pregnancy.
The
objectives are:
-
to quantify and monitor the rate of
mother-to-child transmission of HIV;
-
to identify the clinical,
epidemiological and biological factors associated with
mother-to-child transmission in our setting;
-
and to monitor the
possible negative effects in children exposed to antiretroviral
treatment during pregnancy and early childhood.
Data
have been collected from all HIV positive mothers and their
newborns in 8 hospitals in Madrid and 4 in Barcelona from January
2000. These data include demographic, clinical and biological data
collected during pregnancy, at childbirth, and at 2, 8, 12, and 24
weeks of life of the newborn, and then every 12 months.
Both initial projects, that have been made between the 1st of
January of 2000 and the 31st of December of 2002, has been
prorogued by 6 years more (FIPSE 36352/02 and 36535/05 for Catalonia and
36299/02 and
36531/05
for Madrid), enlarging inclusion
criteria for NENEXP study from HIV positive pregnant
women, and does not have to start off of exposed newborn.
Consequently, the follow-up of the pregnancy as the evolution of
the children are prospective. Since the beginning, these
multi-centre projects were included into the Paediatric Line
from the
Spanish AIDS Research Network (RIS)
del FIS-Ministry of Health (Groups
network number 173).”
Internal documentation of
NENEXP project
Demo NENEXP
Link to the Registry of the Cohort
of HIV infected mother-infants pairs
Related
Text in SIVES-2004 (PDF)
New
Symposium.
Challenges for future: The prevention of
HIV mother-to-child transmission in Catalonia (NENEXP Project)
21 June 2006. Sala d’Actes. Departament de Salut. Generalitat de
Catalunya
New
Project
Leader:
Jesús
Almeda;
Joan Masip
